What's breaking now, across thousands of outlets.
Roche is paying Hansoh $400 million up front in a broad deal involving several ADCs. Elsewhere, another top investor formed a China-focused fund and Ultragenyx sold a second review voucher.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
Der Pharma- und Technologiekonzern stemmt unter seinem neuen Chef Kai Beckmann die nächste Übernahme. Der Deal soll Merck im Geschäft mit seltenen Krankheiten voranbringen.
Wiper Party leader Kalonzo Musyoka has honoured frontline health workers handling Ebola, describing them as among Kenya’s unsung heroes in his Mashujaa Day message to Kenyans.
The proposed changes would implement key healthcare provisions in a government funding package from February. The brunt of the reforms would go into effect in 2028.
The federal government will establish a national-level plant using its own resources to produce modern and effective vaccines for livestock, Prime Minister Shehbaz Sharif said on Monday.
Health authorities have urged parents to ensure that their daughters receive the human papillomavirus (HPV) vaccine under the cervical cancer … Read More The post Govt Urges Parents to Vaccinate Their…
Roche is reviewing all future investments in Germany over health care cost-cutting policies, with a top executive citing a loss of trust
